Hello, everyone, nice to see you again. Another shiny day is emerging here on the Pharmalot corporate campus, where we are hustling to deliver one of the short people to the local schoolhouse. Busy, busy, busy. Meanwhile, those meetings and deadlines loom. We know you relate. So here are a few interesting items to help you along. Have a wonderful day and stay in touch...
Pfizer Pays $240M For Stake In Brazil's Teuto (Reuters)
Vioxx Lawyers Who Led Settlement Will Get $315M (Bloomberg News)
Boehringer's Pradaxa Bloodthinner Wins FDA Approval (Reuters)
Amylin's Diabetes Drug Debacle (TheStreet)
McKesson To Pay $15M To Connecticut For Inflating Prices (CTNow)
Sanofi Wins $442M Judgment Over Plavix Patent (Bloomberg News)
Anti-Counterfeiting Effort Nabs 1M Pills (InPharma-Technologist)
2 Comments
On your Merck/Vioxx® legal fees story:
The judge, in New Orleans federal District Court, actually ordered a total of $1.55 billion to be paid out to the various lawyers. Individual splits (by specific firms and lawyers) are still pending before Judge Fallon.
This is an extraordinary amount of legal fees, but so too, is the $4.85 billion in recoveries acheived, on the over 105 million Vioxx prescriptions written during the period the drug was available in the US markets.
To be fair, thhough, the average hourly billing rate on the case was a little over $440 an hour.
Namaste
Hi Ed -
I have to say I did prefer your old email style. The new style comes in with very small point size.
Just thought you'd like to know.
Thanks, Karl